Milestone Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Milestone Pharmaceuticals (Nasdaq: MIST) has announced that its President and CEO, Joseph Oliveto, will present at two upcoming investor conferences. The events include the Piper Sandler 32^nd Virtual Annual Healthcare Conference and the Evercore ISI 3^rd Annual HealthCONx Conference on December 3, 2020, at 4:20 p.m. ET. A replay of the Piper Sandler fireside chat is available on the company's website, along with a live webcast of the Evercore presentation. Milestone is focused on developing etripamil for cardiovascular treatments.

MONTREAL and CHARLOTTE, N.C., Nov. 23, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will present at the following investor conferences:

• The Piper Sandler 32^nd Virtual Annual Healthcare Conference.
• The Evercore ISI 3^rd Annual HealthCONx Conference on Thursday, December 3, 2020 at 4:20 p.m. Eastern Time.

A replay of the pre-recorded Piper Sandler fireside chat is currently available in the News & Events section of Milestone's website at www.milestonepharma.com, and a live webcast of the Evercore fireside chat can be accessed in the same section of Milestone's website. An archived replay of the webcasts will be available on the same website for approximately 90 days following the presentations.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of etripamil, a Phase 3 clinical-stage program, for the treatment of cardiovascular indications. Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma. 

Contact

David Pitts
Argot Partners
212-600-1902
david@argotpartners.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-upcoming-investor-conferences-301178279.html

SOURCE Milestone Pharmaceuticals, Inc.

FAQ

What conferences will Milestone Pharmaceuticals present at in December 2020?

Milestone Pharmaceuticals will present at the Piper Sandler 32nd Virtual Annual Healthcare Conference and the Evercore ISI 3rd Annual HealthCONx Conference on December 3, 2020.

When is the Evercore ISI HealthCONx Conference presentation?

The Evercore ISI HealthCONx Conference presentation will take place on December 3, 2020, at 4:20 p.m. Eastern Time.

Where can I find the replay of Milestone Pharmaceuticals' investor presentations?

Replays of Milestone Pharmaceuticals' presentations are available in the News & Events section of their website.

What is the focus of Milestone Pharmaceuticals?

Milestone Pharmaceuticals focuses on the development of innovative cardiovascular medicines, specifically etripamil, which is in Phase 3 clinical trials.

What is the ticker symbol for Milestone Pharmaceuticals?

The ticker symbol for Milestone Pharmaceuticals is MIST.